Relationship between epidermal growth factor and its receptor in human benign prostatic hyperplasia

Area of Science:

• Urology
• Molecular Biology
• Oncology

Background:

• Benign prostatic hyperplasia (BPH) is a common condition in aging men.
• Epidermal growth factor (EGF) and its receptor (EGFR) play roles in cell growth and proliferation.
• The specific roles of EGF and EGFR in BPH pathogenesis require further elucidation.

Purpose of the Study:

• To investigate the presence and levels of immunoreactive EGF (irEGF) and EGF receptor (EGFR) in human BPH tissues.
• To explore the relationship between irEGF concentrations and EGFR binding sites in BPH.
• To hypothesize the potential autocrine/paracrine role of EGF in BPH.

Main Methods:

• Analysis of human BPH tissue samples.
• Immunohistochemical detection of irEGF and EGFR.
• Scatchard analysis of [125I]EGF binding to determine receptor affinity and number.
• Correlation analysis between irEGF levels and EGFR expression.

Main Results:

• Both irEGF and EGFR were detected in all examined BPH samples.
• Scatchard analysis revealed two classes of EGF binding sites (high and low affinity).
• A significant inverse linear correlation was observed between intratissular irEGF concentrations and EGFR levels.
• Two distinct sample groups emerged: high irEGF/low EGFR binding sites and low irEGF/high EGFR binding sites.

Conclusions:

• The co-existence of EGF and EGFR in BPH suggests a potential autocrine/paracrine signaling pathway.
• The inverse relationship between EGF and EGFR implies that EGF may regulate its own receptor's cell surface availability.
• These findings highlight a potential therapeutic target for managing BPH.